Study | Year | No. of Patients | Sclerosing Agent | Mean Treatment Sessions (No.) | Complete Response | Partial (≥50%) Response | Partial (<50%) Response | No Response | Complications |
---|---|---|---|---|---|---|---|---|---|
Fukumoto et al2 | 1994 | 3 | Ethanol | 1.0 | 100.0% (3/3) | – | – | None | |
Roh et al5 | 2006 | 12 | OK-432 | 2.3 | 58.3% (7/12) | 25.0% (3/12) | 16.7% (2/12) | Fever | |
Kim et al4 | 2009 | 23 | OK-432 | 1.7 | 60.8% (14/23) | 13.0% (3/23) | 8.7% (2/23) | 17.4% (4/23) | Fever, local pain |
Ohta et al6 | 2010 | 12 | OK-432 | 2.9 | 50.0% (6/12) | 16.7% (2/12) | 8.3% (1/12) | 25.0% (3/12) | Fever |
↵a Numbers in parentheses are the numbers of patients among all those included in the study.